stockrowEdwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +6.00%
- Free cash flow
- −1.84%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow EW
Alert me
Edwards Lifesciences Corporation (EW) Gross margin
Edwards Lifesciences Corporation's gross margin over the twelve months to 30 September 2026 was 78.0%, up 0.0 percentage points from fiscal 2025 (78.0%). Over the past ten years it has ranged from 73.1% (fiscal 2016) to 83.8% (fiscal 2022); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 78.0% | (1.45) |
| FY2024 | 79.5% | (1.01) |
| FY2023 | 80.5% | (3.32) |
| FY2022 | 83.8% | 7.66 |
| FY2021 | 76.1% | 0.77 |
| FY2020 | 75.4% | 0.99 |
| FY2019 | 74.4% | (0.40) |
| FY2018 | 74.8% | 0.25 |
| FY2017 | 74.5% | 1.43 |
| FY2016 | 73.1% | (2.16) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 78.5% | 1.02 |
| Jun 2026 | 77.5% | (0.55) |
| Mar 2026 | 78.0% | (0.14) |
| Dec 2025 | 78.2% | 0.38 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| EW Edwards Lifesciences Corporation | 78.0% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.7% |
| BSX Boston Scientific Corporation compare | 69.1% |
| SYK Stryker Corporation compare | 65.3% |
| MDT Medtronic PLC compare | 65.0% |
| DXCM DexCom, Inc. compare | 63.4% |
| PHG Koninklijke Philips N.V. compare | 46.4% |
| STE STERIS plc compare | 44.6% |
| GEHC GE HealthCare Technologies Inc. compare | 40.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement